• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群在 2 型糖尿病发病机制中的潜在作用 表观遗传学和炎性体。

The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus Epigenetics and Inflammasome.

机构信息

Chitkara School of Health Sciences, Chitkara University, Punjab, India.

Department of Biotechnology, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, Haryana, India.

出版信息

Endocr Metab Immune Disord Drug Targets. 2022;22(14):1331-1343. doi: 10.2174/1871530322666220331152809.

DOI:10.2174/1871530322666220331152809
PMID:35362379
Abstract

The gut microbiota that comprises over 100 trillion microorganisms with a weight of about 1-2 kg is regarded as one of the most crucial players in the regulation of the metabolic health of host organisms. In recent years, the incidence of type 2 diabetes mellitus (T2DM), characterized by high levels of sugar in the blood, has been exponentially increasing due to obesity and other lifestyle risk factors. It was shown that dysbiosis, change in the overall composition, and diversity of gut microflora can result in T2DM. Conversely, the microbial composition can also influence the epigenetics of the host organism (DNA methylation as well as histone modifications), which might have a potential effect on the metabolic health of the individual. Another mechanism of gut microbiota in the development of T2DM is through the involvement of nucleotide-binding oligomerization domain, Leucine-rich Repeat, and Pyrin domain containing 3 (NLRP3) inflammasome, a part of the innate immune system. NLRP3 inflammasome produces inflammatory cytokines, promoting the secretion of microbial antigens in the intestinal epithelium. Therefore, it is important to understand the possible connecting link between gut microbiota and T2DM that might help in the modulation of gut microflora to better understand the disease. In this review, the role of gut microbiota in the pathogenesis of T2DM will be discussed.

摘要

肠道微生物群由超过 1000 万亿个微生物组成,重量约为 1-2 公斤,被认为是调节宿主生物代谢健康的最重要因素之一。近年来,由于肥胖和其他生活方式风险因素,以血液中糖分水平高为特征的 2 型糖尿病(T2DM)的发病率呈指数级增长。研究表明,肠道微生物菌群的失调、整体组成和多样性的改变可能导致 T2DM。相反,微生物组成也可以影响宿主生物的表观遗传学(DNA 甲基化以及组蛋白修饰),这可能对个体的代谢健康产生潜在影响。肠道微生物群在 T2DM 发展中的另一个机制是通过核苷酸结合寡聚结构域、富含亮氨酸重复和吡喃结构域包含 3(NLRP3)炎性小体的参与,这是先天免疫系统的一部分。NLRP3 炎性小体产生炎症细胞因子,促进肠道上皮中微生物抗原的分泌。因此,了解肠道微生物群与 T2DM 之间可能存在的联系非常重要,这有助于调节肠道微生物群,从而更好地了解该疾病。本文将讨论肠道微生物群在 T2DM 发病机制中的作用。

相似文献

1
The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus Epigenetics and Inflammasome.肠道微生物群在 2 型糖尿病发病机制中的潜在作用 表观遗传学和炎性体。
Endocr Metab Immune Disord Drug Targets. 2022;22(14):1331-1343. doi: 10.2174/1871530322666220331152809.
2
Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes.NLRP3 炎性小体在糖尿病中的调节机制。
Biomolecules. 2019 Dec 9;9(12):850. doi: 10.3390/biom9120850.
3
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome.肠道微生物失调通过脂多糖和葡萄糖诱导的 NLRP3 炎性小体激活促进与年龄相关的心房颤动。
Cardiovasc Res. 2022 Feb 21;118(3):785-797. doi: 10.1093/cvr/cvab114.
4
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?肠道菌群-肠-脑轴在健康和疾病中的作用:NLRP3 炎性小体是否处于肠道菌群-肠-脑通讯的十字路口?
Prog Neurobiol. 2020 Aug;191:101806. doi: 10.1016/j.pneurobio.2020.101806. Epub 2020 May 28.
5
[Inflammation, obesity and type 2 diabetes. Role of the NLRP3 inflammasome and gut microbiota].[炎症、肥胖与2型糖尿病。NLRP3炎性小体和肠道微生物群的作用]
Rev Med Liege. 2022 May;77(5-6):310-315.
6
The relationship with and effect of oral microbiota on NLRP3 inflammatory pathway in type 2 diabetes mellitus.2型糖尿病中口腔微生物群与NLRP3炎症通路的关系及影响
Arch Oral Biol. 2023 Nov;155:105801. doi: 10.1016/j.archoralbio.2023.105801. Epub 2023 Sep 9.
7
Gut Microbiota Alleviates Intestinal Injury Induced by Extended Exposure to Light via Inhibiting the Activation of NLRP3 Inflammasome in Broiler Chickens.肠道微生物群通过抑制 NLRP3 炎性体在肉鸡中的激活缓解延长光照引起的肠道损伤。
Int J Mol Sci. 2024 Jun 18;25(12):6695. doi: 10.3390/ijms25126695.
8
The role of the microbiome and the NLRP3 inflammasome in the gut and lung.微生物组和 NLRP3 炎性体在肠道和肺部中的作用。
J Leukoc Biol. 2020 Sep;108(3):925-935. doi: 10.1002/JLB.3MR0720-472RR. Epub 2020 Aug 17.
9
The Microbiota-Inflammasome Hypothesis of Major Depression.重度抑郁症的微生物群-炎症小体假说。
Bioessays. 2018 Sep;40(9):e1800027. doi: 10.1002/bies.201800027. Epub 2018 Jul 13.
10
The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis.NLRP3 炎性体与动脉粥样硬化中肠道微生物组的串扰。
Pharmacol Res. 2022 Jul;181:106289. doi: 10.1016/j.phrs.2022.106289. Epub 2022 Jun 6.

引用本文的文献

1
Association of dietary index for gut microbiota and all-cause and cardiovascular mortality in patients with diabetes or prediabetes.糖尿病或糖尿病前期患者肠道微生物群饮食指数与全因死亡率和心血管死亡率的关联
World J Diabetes. 2025 Jul 15;16(7):107111. doi: 10.4239/wjd.v16.i7.107111.
2
The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature.神经炎症性疾病发病机制中的微生物群-肠道-脑-免疫接口:新兴文献的叙述性综述。
Front Immunol. 2024 May 16;15:1365673. doi: 10.3389/fimmu.2024.1365673. eCollection 2024.

本文引用的文献

1
Association of risk factors with type 2 diabetes: A systematic review.风险因素与2型糖尿病的关联:一项系统综述。
Comput Struct Biotechnol J. 2021 Mar 10;19:1759-1785. doi: 10.1016/j.csbj.2021.03.003. eCollection 2021.
2
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. doi: 10.2337/dc21-S002.
3
First-line treatment for type 2 diabetes: is it too early to abandon metformin?2型糖尿病的一线治疗:现在放弃二甲双胍是否为时过早?
Lancet. 2020 Nov 28;396(10264):1705-1707. doi: 10.1016/S0140-6736(20)32523-X.
4
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.益生菌、益生元或合生菌对糖尿病患者代谢结局的影响:系统评价和荟萃分析。
Diabetologia. 2021 Jan;64(1):26-41. doi: 10.1007/s00125-020-05295-1. Epub 2020 Oct 13.
5
Microbiota-Related Metabolites and the Risk of Type 2 Diabetes.微生物群相关代谢物与 2 型糖尿病风险。
Diabetes Care. 2020 Jun;43(6):1319-1325. doi: 10.2337/dc19-2533. Epub 2020 Apr 15.
6
Histone H4K20 Demethylation by Two hHR23 Proteins.两个 hHR23 蛋白对组蛋白 H4K20 的去甲基化作用。
Cell Rep. 2020 Mar 24;30(12):4152-4164.e6. doi: 10.1016/j.celrep.2020.03.001.
7
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes.肥胖与糖尿病中肠道微生物群的表观遗传联系
Front Genet. 2020 Jan 15;10:1329. doi: 10.3389/fgene.2019.01329. eCollection 2019.
8
Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice.粪菌移植改善 db/db 小鼠的代谢和肠道微生物组组成。
Acta Pharmacol Sin. 2020 May;41(5):678-685. doi: 10.1038/s41401-019-0330-9. Epub 2020 Jan 14.
9
Role of gut microbiota in type 2 diabetes pathophysiology.肠道微生物群在 2 型糖尿病发病机制中的作用。
EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3.
10
Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes.NLRP3 炎性小体在糖尿病中的调节机制。
Biomolecules. 2019 Dec 9;9(12):850. doi: 10.3390/biom9120850.